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The detection of viral nucleic acid by real time RT-PCR is the main confirmative diagnostic method for COVID-
19 in clinical practice in China and worldwide. However, its sensitivity is unclear. Here we report two cases in a 
family in Guizhou, southwestern China. The father had a history of long stay in Wuhan. Surprisingly, although 
the son was diagnosed positive using the nasopharyngeal swab specimen and the rRT-PCR method, the father 
was diagnosed negative continuously for multiple times. Only after the alveolar lavage fluid sample was used, the 
father’s rRT-PCR diagnosis turned positive. Their CT diagnosis and clinical symptoms did not completely align 
with their rRT-PCR diagnostic results. The underlying mechanisms and their implications to clinical practice 
are discussed. 
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Introduction 
The recent outbreak of COVID-19 caused by SARS-CoV-
2 poses a huge threat to global public health[1-3]. As of May 22, 
2020, 84,522 cases of COVID-19 have been diagnosed in 
China, and 4,645 have died. New cases have been reported in 
Japan, Korea, Thailand, the United States[4], Germany, Italy, 
Australia, and other countries outside China[5]. A total of 
5,084,920 cases have been reported in at least 214 countries. 
SARS-CoV-2 belongs to the same coronavirus family as 
SARS-CoV and MERS-CoV. The latter two have caused 
severe SARS and MERS epidemics in China and the Middle 
East, respectively, causing 10% (916/8098) and 34.4% 
(851/2468) deaths[6,7]. At present, the source, transmission  
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Figure 1. Timeline of disease course and laboratory findings of the father and son patients. The results were recorded by starting from the 
initial presentation of illness (the father on Jan 23 and the son on Jan 26) and their days of hospitalization. The son was discharged on February 12. 
The father was transferred to another hospital on February 13, and his health condition has improved since then. *NT: denotes not tested. $ The 
cycle threshold (Ct) of at least one target gene (ORF1a/b or N) lies between the positive Ct and the negative Ct. 
 
route, pathogenic mechanism, epidemiological characteristics, 
and disease spectrum of this novel coronavirus, SARS-CoV-
2, are not clear. There is also a lack of targeted therapies and 
vaccines for COVID-19.  
With the COVID-19 outbreak quickly spreading worldwide, 
it is critical to ensure the accurate and fast diagnosis. The 
detection of viral nucleic acid by real-time reverse 
transcription-polymerase chain reaction (rRT-PCR) is the 
main method for confirming diagnosis in clinical practice. A 
positive result suggests the presence of the unique SARS-
CoV-2 viral sequence. The accuracy is considered high given 
the sequence uniqueness. However, the sensitivity of the assay 
is not well studied and reported.  
Here we report two cases in Guiyang, Guizhou, 
southwestern China, belonging to one family. The father lived 
in Wuhan for a long time, and became ill at 1 day after 
returning to Guiyang. The son developed symptoms at 4 days 
after his father turned to Guiyang. The son patient was 
diagnosed COVID-19 positive quickly using the rRT-PCR on 
the nasopharyngeal specimen. However, the father’s rRT-PCR 
test returned negative results twice with nasopharyngeal 
swabs. Once after using alveolar lavage fluid (BALF) 
specimen collected at Day 9 after illness onset, his rRT-PCR 
test showed positive. We have also collected their 
epidemiological and clinical characteristics. We found that the 
CT results did not align with the rRT-PCR results. The mother 
lived with the son and father but did not get infected.  
Cases Description 
Father patient case 
A 53-year-old male patient was admitted and hospitalized 
to our hospital on 29 January 2020 (Figure 1). His symptoms 
included fever (maximum body temperature of 38.8℃), chills, 
coughing, fatigue, and shortness of breath. The patient 
disclosed that he had returned to his wife/son’s house in 
Guiyang on 22 January 2020 from Wuhan. He had a fever on 
the next day after he returned Guiyang. The symptom was 
once reduced after medication. Previously, the patient had a 
long stay in Wuhan, but no exposure history to South China 
seafood market, and had not consumed any wild animal. He 
had a medical history of well controlled hypertension.  
Chest computerized tomography (CT) (Figure 2A) on the 
day of admission revealed multiple ground-glass changes in 
the lung, with the lesions being subpleural. Physical 
examination revealed no significant findings except for the 
congestion of the pharynx and elevated body temperature. But 
his peripheral blood oxygen saturation (SPO2) was only 93% 
on room air. His nasopharyngeal swabs were collected daily 
for two days after his admission and used for the SARS-CoV-
2 nucleic acid rRT-PCR test according to the China National 
Health Committee guidelines[8]. Both results were negative. 
Considering his clinical presentation of viral pneumonia but 
negative result of influenza A virus, influenza B virus antigen 
in a patient with the appropriate epidemiological risk, patient’s 
alveolar lavage fluid was collected on the 3rd day after his 
admission, and the SARS-CoV-2 rRT-PCR test showed 
positive. This confirmed that the patient had COVID-19.   
For the patient’s treatment, he was given oxygen supple- 
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Figure 2. Chest CT images of a 53-year-old father patient of COVID-19. (A) Taken on January 29, 2020 
(Illness Day 7, Hospital Day 1). Multifocal ground-glass bilateral opacities in lung, and the lesions mainly 
under the pleura (arrowheads). (B) January 31: increased opacities in lung. (C) February 9: absorption of 
bilateral ground glass and fibrotic changes in lung. 
 
mentation through the mask. The medications he took 
included interferon alpha-2b (5 million units, twice daily, 
atomized inhalation), lopinavir plus ritonavir (500 mg, twice a 
day, oral) and moxifloxacin (0.4 g, once a day, intravenously).  
After admission, the patient’s chest tightness and shortness 
of breath worsened, his temperature reached 38.5-38.9℃ for 
72 hours. His oxygenation worsened, the oxygenation index 
was 268 mmHg, and respiratory failure combined. After 48 
hours, chest CT (Figure 2B) showed progressive leaching and 
diffuse glands in the patient’s lungs. Because the patient has 
shortness of breath and hypoxemia, methylprednisolone (40 
mg, twice a day×5d, intravenously) is used to reduce 
inflammation of the lung. 
On the 5th day of hospitalization, it was found that his 
lymphocyte and cellular immune function was reduced 
(Supplemental Table 1), and thus thymopolypeptides was 
given to improve the body’s immunity. From the 4th day of 
hospitalization, the patient’s temperature dropped to normal. 
From the 5th day, the patient's symptoms (such as cough and 
dyspnea) gradually reduced and then disappear, and the 
oxygen saturation was increased to 95% after his receiving 
nasal catheter oxygen therapy (FiO2:0.29). On the 9th day, the 
SARS-CoV-2 RNA test of the alveolar lavage fluid showed 
suspiciously positive. On the 12th day, the chest was reviewed. 
CT showed the absorption of bilateral ground glass and 
fibrotic changes in lung (Figure 2C), which was better than the 
lung profile found in the previous examination. On the 12th 
day, the alveolar lavage fluid detection of SARS-CoV-2 RNA 
by rRT-PCR still showed a positive result. On the 14th day, the 
nasopharyngeal swab for SARS-CoV-2 nucleic acid was 
negative. On the 16th day of hospitalization, he was transferred 
to another designated hospital for inpatient treatment, and his 
health condition has continuously improved since then.  
Son patient case 
The above father patient’s son, a 25-year-old man with a 3-
day history of mild fever (up to a maximum of 37.8℃) and 
cough, was admitted to our hospital on 29 January 2020, the 
same day when his father was hospitalized (Figure 1). He had 
no chest pain and shortness of breath. Physical examination 
revealed no significant findings. His oxygen saturation was 
94%-98% on room air. Chest computed tomographic images 
showed ground glass opacity in right lung middle lobe and left 
basilar (Figure 3A). SARS-Cov-2 RNA was detected and 
confirmed in nasopharyngeal swabs by rRT-PCR for two 
continuous days after his admission. The patient underwent an 
"appendectomy" four years ago without other underlying 
diseases. Laboratory findings were in the normal range except 
for lymphopenia and elevated lactate dehydrogenase 
(Supplemental Table 2). Nasopharyngeal swabs were negative 
for RNA of influenza virus A and influenza virus B.  
After admission, the son patient was administered abidol 
hydrochloride, lopinavir plus ritonavir (500 mg, twice a day, 
oral), interferon alpha-2b (5 million units, twice daily, 
atomized inhalation) as antiviral therapy, and moxifloxacin 
(0.4 g, once a day, intravenously) to prevent secondary 
infections and received nasal catheter oxygen therapy (FiO2: 
0.29). Due to his cellular immune disorders (Supplemental 
Table 2), the patient was given thymopolypeptides to improve 
the immunity. Due to nausea and bloating, pantoprazole and  
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Figure 3. Chest CT images of a 22-year-old son patient of COVID-19. (A) 
Taken on January 29, 2020 (Illness Day 4, Hospital Day 1), showing bilateral 
ground glass opacities (arrowheads). (B) February 9: absorbed and reduced 
shadows in lung. 
 
 
Clostridium butyricum were administered.  
After admission, the patient had chest tightness and dry 
cough, but no fever. Symptoms gradually eased after treatment. 
On the 12th day of admission (February 9, 2020), a review of 
chest CT showed that compared with the film at 10 days ago, 
the range of opacities was absorbed and reduced (Figure 3B). 
According to the persistent negative results of SARS-CoV-2 
(nasopharyngeal swab specimens, rRT-PCR) on day 13 and 
14, as well as the lung lesions partially absorbed, the patient 
was discharged on day 15 (February 12) (Figure 1).  
As another member of the family, the mother had been 
living with his son in Guiyang before his sickness, and has not 
had an illness so far. The mother was also tested together with 
her son and husband. Both SARS-CoV-2 nucleic acid tests 
using nasopharyngeal swabs and BALF were normal. Her CT 
scanning examinations were also normal. Overall, the mother 
appeared to be less susceptible and more resistant to the 
SARS-CoV-2 infection. 
Discussion 
In the family cases, one major unusual finding is related to 
diagnosis using the SARS-CoV-2 nucleic acid real time RT-
PCR. Since the day of hospital admission, the son’s 
temperature had been normal, but his two continuous rRT-
PCR tests were positive with his nasopharyngeal samples. 
However, the father patient had fever on the day of admission 
and for a few days afterwards, but his rRT-PCR test with 
nasopharyngeal specimen was negative for all the times tested, 
and only the rRT-PCR test with his alveolar lavage fluid 
samples was positive. The false negative of nucleic acid 
detection with the nasopharyngeal samples is likely due to the 
no or low viral load in the collected samples. A recent study 
of 17 COVID-19 patients in Zhuhai, China reported that high 
viral load was detected in most nasal swabs and throat swabs 
shortly after the onset of symptoms, and decreased 
significantly after 1 week[9]. Another recent study using 82 
infected individuals showed that the viral loads of SARS-
CoV-2 in throat swab and sputum samples peaked at around 
5-6 days after symptoms onset[10]. Our findings with the 
nasopharyngeal swabs on the father and son patients are 
aligned with this report. However, these two recent studies[9,10] 
did not have samples of alveolar lavage fluid. Only when the 
alveolar lavage fluid samples from the father patient were used, 
positive results showed up. Combining all these results, we 
can reasonably hypothesize that as the disease progresses, the 
virus quickly replicates and gradually transferred into the lung 
area, leading to the increasingly lower viral load in the upper 
respiratory tract and increasingly higher viral load in the lower 
respiratory tract. This viral transferring trend might be the 
reason why the father’s nasopharyngeal swab test turned to be 
false negative at day 7 after disease onset. Given also that the 
same diagnosis obtained positive result with the son patient at 
day 4 after disease onset, we may conclude that different 
stages of the disease course may affect the true or false 
diagnosis result with the rRT-PCR method, which is an alarm 
for our routine diagnosis practice. A remaining question is 
when the lung samples start to show positive results with rRT-
PCR.  
In our father and son cases, the nucleic acid test results were 
not completely synchronized with the dynamics of CT images 
and clinical symptoms. While the RT-PCR diagnosis results 
differ significantly, the CT tests at the 1st day of hospitalization 
were positive for both father and son patients. On the 18th day 
after the disease onset, although the father's BALF nucleic 
acid was positive, his chest CT showed that the lung shadows 
had improved compared with the most severe CT, his 
temperature has already returned to normal, and the symptoms 
of cough and shortness of breath had also eased. Therefore, 
the remission of symptoms may precede the elimination of the 
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virus. After the son was hospitalized, he no longer had fever, 
but his viral nucleic acid test was still positive. Although there 
has been much discussion on the sensitivity of nucleic acid 
detection, the role of the etiology conformation in the 
diagnosis of infectious diseases is undoubted. However, a 
comprehensive epidemiological history, clinical symptoms, 
and chest imaging are needed for consideration, as illustrated 
in the patient case. Improving sample quality (including 
optimized sampling locations and sampling techniques) is an 
important factor in improving accuracy.  
Another interesting observation is related to our drug 
therapy to these patients. Both patients had decreased 
lymphocyte counts and weakened cellular immune functions 
(Supplemental Table 1 and 2). Accordingly, they both 
received the immunomodulatory therapy using the thymosin 
hormone, which is able to stimulate the production of T cells. 
Eventually the cellular immune function of the patients 
improved and their lymphocytes also returned to normal. In 
the first report of the pathological anatomy of a COVID-19 
patient, Xu et al. showed that the counts of CD4+ and CD8+ 
lymphocytes in the peripheral blood of the patient were greatly 
reduced while their cell status hyperactivated, showing severe 
immune injury in this patient[11]. Our treatment of the two 
patients with the immunomodulatory drug might have resulted 
in their increased production of T cells and thus helped their 
immune systems fight against the infections. It is also noted 
that although the symptoms were relieved, the drug therapy 
results might not promptly change the diagnosis results within 
a short period of time.   
Overall, this is the first case report that shows the distinct 
profiles of diagnosis of father and son patients with COVID-
19 using nasopharyngeal and alveolar lavage fluid samples. 
One take-home message is that the sensitivity of the rRT-PCR 
method depends on the location of collected samples in 
different disease stages. The result may be negative with the 
nasopharyngeal samples at day 7 after disease onset as shown 
in the father patient in this report. However, the lung samples 
may become more sensitive at the late stage of infection. A 
reality is that it is not a conventional method in clinical to use 
lower respiratory tract samples for diagnosis due to its relative 
difficulty in sample collection. In our cases, BALF needs to be 
obtained through invasive procedures, which increases the 
pain of patients and increases the risk of infection transmission. 
However, for more reliable diagnosis, we would propose the 
consideration of the nucleic acid testing using the lower 
respiratory tract samples, especially for patients at a 
potentially later stage of infection and whose epidemiological 
and other clinical manifestation are highly suggestive (for 
example, typical CT images, like our patients). 
Mechanistically, it is critical to understand the viral load and 
distribution at different stages in the course of the disease, and 
their relationships with the severity and transmission of the 
disease. Solving these problems through further research will 
help diagnose and control the COVID-19 disease.  
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White-cell count, ×109/L 3.5-9.5 3.57 3.00 11.22 6.75 7.56 — 
Absolute neutrophil count, 
×109/L 
1.8-6.3 1.91  9.92 5.44 5.18 — 
Absolute lymphocyte 
count, ×109/L 
1.1-3.2 1.2 1.08 0.76 0.80 1.27 — 
LDH, U/L 120-150 303 506 288 307 225 — 
Creatine kinase, U/L 50-310 402 399 214 199 38 — 
Creatine kinase-MB, U/L 0-25 22 — — 22 — — 
PaO2:FiO2, mm Hg >300 — 268 368  —  
CD3+ cell count, /μl 770-2860 — — 388 356 — 476 
CD4+ cell count, /μl 500-1440 — — 260 192 — 280 
CD8+ cell count, /μl 238-1250 — — 104 140 — 168 
CD4/CD8 1-2.47 — — 2.50 1.37  1.67 
C-reactive protein, mg/L 0-5 — 43.58 19.76 5.45 93.97 80.39 
Procalcitonin, ng/mL 0-0.046 0.08 0.06 0.07 0.04  0.05 
*The table shows that the lymphocyte counts of patient on the 3rd, 5th and 8th days of hospitalization all decreased, but returned 
to normal on the 13th day. The counts of CD3+, CD4+, and CD8+ lymphocytes all decreased on the 5th and 8th day of 
hospitalization, and then increased on the 15th day, but did not return to normal. The patient's PaO2: FiO2 decreased on the 
3rd day of hospitalization and returned to normal on the 5th day. The patient's LDH and CRP increased slightly during the 
hospitalization. 
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White-cell count, ×109/L 3.5-9.5 4.13 3.25 4.26 4.26 9.88 5.6 
Absolute neutrophil count, 
×109/L 
1.8-6.3 2.66 1.28 1.71 2.14 8.01 2.72 
Absolute lymphocyte 
count, ×109/L 
1.1-3.2 0.86 1.54 1.92 1.6 1.10 2.05 
LDH, U/L 120-150 181 179 153 128 127 143 
Creatine kinase, U/L 50-310 107 — 54 — 37 22 
Creatine kinase-MB, U/L 0-25 9 — 15 — 7 9 
CD3+ cell count, /μl 770-2860 — — — 1040 412 1072 
CD4+ cell count, /μl 500-1440 — — — 276 144 464 
CD8+ cell count, /μl 238-1250 — — — 696 240 536 
CD4/CD8 1-2.47 — — — 0.40 0.60 0.87 
C-reactive protein, mg/L 0-5 1.10 0.83 2.19 0.9 0.24 2.37 
Procalcitonin, ng/mL 0-0.046 0.06 — 0.03 0.03 0.03 0.11 
*The table shows that the patient's lymphocyte count decreased on the first day of hospitalization, and then returned to normal. 
The CD3+ lymphocyte count decreased on the 10th day and returned to normal on the 14th day. The CD4+ lymphocyte count 
decreased on both the 5th and 10th days of hospitalization, but on the 14th day, the CD4+ lymphocyte count increased to close 
to normal. The patient's LDH increased slightly during the first 4 days of hospitalization. 
 
